Synthesis, stability and in vitro dermal evaluation of aminocarbonyloxymethyl esters as prodrugs of carboxylic acid agents. 2002

Eduarda Mendes, and Tânia Furtado, and João Neres, and Jim Iley, and Tomi Jarvinen, and Jarkko Rautio, and Rui Moreira
CECF, Faculdade de Farmácia da Universidade de Lisboa, 1699 Lisbon Codex, Portugal. ermendes@ff.ul.pt

Aminocarbonyloxymethyl esters based on (S)-amino acid carriers were synthesised and evaluated as potential prodrugs of carboxylic acid agents. In addition, the compounds were evaluated as topical prodrugs with the aim of improving the dermal delivery of two non-steroidal anti-inflammatory agents: naproxen and flufenamic acid. The lipophilicities of these compounds were determined and their hydrolyses in aqueous solutions and in human plasma were examined. Compounds containing a secondary carbamate group were hydrolysed at pH 7.4 by two different routes: (i) direct nucleophilic attack at the ester carbonyl carbon leading to the release of the parent carboxylic acid and (ii) intramolecular rearrangement involving an O-->N acyl migration, leading to the formation of the corresponding amide. The rearrangement pathway is highly dependent on the size of the carboxylic acid and amino acid substituents, being eliminated when the amino acid is valine or leucine. In contrast, compounds decomposed in plasma exclusively through ester hydrolysis, most releasing the parent carboxylic acid quantitatively with half-lives shorter than 5 min. The permeation of selected prodrugs across excised postmortem human skin was studied in vitro. All prodrugs evaluated exhibited a lower flux than the corresponding parent carboxylic acid. The poor skin permeation observed for compounds is most probably due to their low aqueous solubility and high partition coefficient.

UI MeSH Term Description Entries
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Eduarda Mendes, and Tânia Furtado, and João Neres, and Jim Iley, and Tomi Jarvinen, and Jarkko Rautio, and Rui Moreira
April 1988, Journal of pharmaceutical sciences,
Eduarda Mendes, and Tânia Furtado, and João Neres, and Jim Iley, and Tomi Jarvinen, and Jarkko Rautio, and Rui Moreira
March 2006, The Journal of pharmacy and pharmacology,
Eduarda Mendes, and Tânia Furtado, and João Neres, and Jim Iley, and Tomi Jarvinen, and Jarkko Rautio, and Rui Moreira
December 1998, Journal of pharmaceutical sciences,
Eduarda Mendes, and Tânia Furtado, and João Neres, and Jim Iley, and Tomi Jarvinen, and Jarkko Rautio, and Rui Moreira
August 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Eduarda Mendes, and Tânia Furtado, and João Neres, and Jim Iley, and Tomi Jarvinen, and Jarkko Rautio, and Rui Moreira
February 2010, Bioorganic & medicinal chemistry letters,
Eduarda Mendes, and Tânia Furtado, and João Neres, and Jim Iley, and Tomi Jarvinen, and Jarkko Rautio, and Rui Moreira
December 1999, Journal of medicinal chemistry,
Eduarda Mendes, and Tânia Furtado, and João Neres, and Jim Iley, and Tomi Jarvinen, and Jarkko Rautio, and Rui Moreira
January 1996, Die Pharmazie,
Eduarda Mendes, and Tânia Furtado, and João Neres, and Jim Iley, and Tomi Jarvinen, and Jarkko Rautio, and Rui Moreira
August 1999, Pharmaceutical research,
Eduarda Mendes, and Tânia Furtado, and João Neres, and Jim Iley, and Tomi Jarvinen, and Jarkko Rautio, and Rui Moreira
September 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Eduarda Mendes, and Tânia Furtado, and João Neres, and Jim Iley, and Tomi Jarvinen, and Jarkko Rautio, and Rui Moreira
August 2013, Medicinal chemistry (Shariqah (United Arab Emirates)),
Copied contents to your clipboard!